Archived Newsletters

31. 06.03.25 -- Unlock Higher Drug Loads With Nanoformed API Technology 6/3/2025

    06/03/25 Outsourced Pharma Newsletter

32. 06.03.25 -- Is Early Automation The Key To Scalable Cell Therapy Manufacturing? 6/3/2025
    06/03/25 Outsourced Pharma Newsletter
33. Challenges In ADC Process Development 6/2/2025
    [UNSCHEDULED]
34. 06.02.25 -- STREAM Edition: Evolve Or Fade Away? Biotech's Outsourcing Moment In Trump's Tariff Tangle 6/2/2025

    06/02/25 Outsourced Pharma Newsletter

35. 05.30.25 -- Partnering For Efficient And Reliable Fill/Finish Operations 5/30/2025
    05/30/25 Outsourced Pharma Newsletter
36. 05.30.25 -- To Enhance Biotech Investments, Involve CDMOs Early In CMC Decisions 5/30/2025
    05/30/25 Outsourced Pharma Newsletter
37. 05.29.25 -- Enhance Safety In Cell And Gene Therapies 5/29/2025

    05/29/25 Outsourced Pharma Newsletter

38. 05.29.25 -- Take Your Small Molecule Drug Development To The Next Level 5/29/2025
    05/29/25 Outsourced Pharma Newsletter
39. 05.29.25 -- Squeezing CDMOs Dry? One Big Pharma VP Says Enough Is Enough 5/29/2025
    05/29/25 Outsourced Pharma Newsletter
40. 05.28.25 -- Discover Partners Focused On Cell & Gene Therapy 5/28/2025
    05/28/25 Outsourced Pharma Newsletter